Related Experiment Videos
Characterization of single-cell clonal lines derived from HSV-2-transformed mouse cells
Intervirology
|January 1, 1975
Summary
Herpes simplex virus type 2 (HSV-2) transformed cell lines (H238) were cloned. These cloned cell lines induce tumors in mice but do not elicit HSV-neutralizing antibodies, unlike the parent line.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Herpes simplex virus type 2 (HSV-2) can transform mammalian cells.
- Continuous cell lines derived from HSV-2 infected cells are valuable tools for cancer research.
Purpose of the Study:
- To characterize cloned cell lines derived from an HSV-2 transformed cell line (H238).
- To assess the tumor-inducing potential and immunogenicity of these cloned cell lines in vivo.
Main Methods:
- Cell culture and soft agar cloning techniques were used to derive clonal cell lines from H238.
- Immunofluorescence assays were performed to detect cytoplasmic antigens using specific antisera.
- Tumorigenicity was evaluated by subcutaneous inoculation of cloned cells into immunocompetent mice.
- Humoral immune response was assessed by measuring HSV-neutralizing antibodies in tumor-bearing hosts.
Main Results:
- Cloned cell lines derived from H238 expressed cytoplasmic antigens reactive with HSV-2 antiserum.
- All cloned cell lines induced tumors in mice with 100% incidence at an inoculum of 10(6) cells.
- Unlike the parent H238 line, the cloned cell lines failed to elicit HSV-neutralizing antibodies in tumor-bearing mice.
Conclusions:
- Cloned cell lines derived from HSV-2 transformed cells retain tumorigenic properties.
- These cloned cell lines represent a valuable model for studying HSV-2 induced oncogenesis and immune evasion mechanisms.
- The inability of cloned lines to elicit neutralizing antibodies suggests a potential role for viral antigens in immune evasion during tumor development.